Clinical Trial Update: Circulating Tumor Cells in Operative Blood

View source ↗

Summary

This update describes a completed clinical trial evaluating circulating tumor cells in operative blood from patients with pancreatic ductal adenocarcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Ductal Adenocarcinoma

Snippet

Sponsor: University of Florida | Conditions: Carcinoma, Pancreatic Ductal | Status: COMPLETED